Loading…
Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study
The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) wo...
Saved in:
Published in: | European journal of clinical microbiology & infectious diseases 2020-04, Vol.39 (4), p.717-721 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343 |
---|---|
cites | cdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343 |
container_end_page | 721 |
container_issue | 4 |
container_start_page | 717 |
container_title | European journal of clinical microbiology & infectious diseases |
container_volume | 39 |
creator | Alicja, Ekiel Małgorzata, Romanik Małgorzata, Aptekorz Elżbieta, Semik-Grabarczyk Paweł, Cieślik Dominika, Smolec Jarosław, Jóźwiak Michał, Holecki Gayane, Martirosian |
description | The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups,
U. parvum
occurred significantly more frequently.
M. genitalium
was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs.
Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain. |
doi_str_mv | 10.1007/s10096-019-03783-w |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2336999692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2336999692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</originalsourceid><addsrcrecordid>eNp9kUFP3DAQha2qqCy0f4BDZakXOARsj7OOe6sQBaSVWqnt2XKcCRsUx6mddJV_X9MFKnHgMpbl770ZzyPkhLNzzpi6SLnqdcG4LhioCordG7LiEspCgoK3ZMU0yEIrAYfkKKV7lkWVUu_IIfAKRMXUimy_R_xjexwc0tDSOYY7HLrJ9tQvLoy9Td4m2g10Fzzm2k1bmpY0oe8c7edxThTjMm3R2ymkfDv9sbk6-0zHiH3nu8HGhaZpbpb35KC1fcIPj-cx-fX16uflTbH5dn17-WVTOFDlVEihObSWNXlEga1swCmnQNaMubIRCrGubWtbXmpXoZLIhKjdupWW1RxBwjE53fuOMfyeMU3Gd8lh39sBw5yMAFhrrddaZPTTC_Q-zHHI02VK5d1VlS4zJfaUiyGliK0ZY-fzvwxn5iEHs8_B5BzMvxzMLos-PlrPtcfmWfK0-AzAHkj5abjD-L_3K7Z_AXb2lYM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2379348895</pqid></control><display><type>article</type><title>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</title><source>Springer Nature</source><creator>Alicja, Ekiel ; Małgorzata, Romanik ; Małgorzata, Aptekorz ; Elżbieta, Semik-Grabarczyk ; Paweł, Cieślik ; Dominika, Smolec ; Jarosław, Jóźwiak ; Michał, Holecki ; Gayane, Martirosian</creator><creatorcontrib>Alicja, Ekiel ; Małgorzata, Romanik ; Małgorzata, Aptekorz ; Elżbieta, Semik-Grabarczyk ; Paweł, Cieślik ; Dominika, Smolec ; Jarosław, Jóźwiak ; Michał, Holecki ; Gayane, Martirosian</creatorcontrib><description>The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups,
U. parvum
occurred significantly more frequently.
M. genitalium
was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs.
Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-019-03783-w</identifier><identifier>PMID: 31832807</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Autoimmune diseases ; Biomedical and Life Sciences ; Biomedicine ; Chronic conditions ; Etiology ; Internal Medicine ; Lupus ; Medical Microbiology ; Original Article ; Systemic lupus erythematosus</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2020-04, Vol.39 (4), p.717-721</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>European Journal of Clinical Microbiology and Infectious Diseases is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</citedby><cites>FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</cites><orcidid>0000-0002-4603-9758 ; 0000-0002-3289-1050 ; 0000-0002-7343-4702 ; 0000-0002-0311-0884 ; 0000-0001-8601-1752 ; 0000-0002-3723-3591 ; 0000-0002-2998-6542 ; 0000-0003-0377-9833 ; 0000-0002-7871-528X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31832807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alicja, Ekiel</creatorcontrib><creatorcontrib>Małgorzata, Romanik</creatorcontrib><creatorcontrib>Małgorzata, Aptekorz</creatorcontrib><creatorcontrib>Elżbieta, Semik-Grabarczyk</creatorcontrib><creatorcontrib>Paweł, Cieślik</creatorcontrib><creatorcontrib>Dominika, Smolec</creatorcontrib><creatorcontrib>Jarosław, Jóźwiak</creatorcontrib><creatorcontrib>Michał, Holecki</creatorcontrib><creatorcontrib>Gayane, Martirosian</creatorcontrib><title>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups,
U. parvum
occurred significantly more frequently.
M. genitalium
was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs.
Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.</description><subject>Autoimmune diseases</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Chronic conditions</subject><subject>Etiology</subject><subject>Internal Medicine</subject><subject>Lupus</subject><subject>Medical Microbiology</subject><subject>Original Article</subject><subject>Systemic lupus erythematosus</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kUFP3DAQha2qqCy0f4BDZakXOARsj7OOe6sQBaSVWqnt2XKcCRsUx6mddJV_X9MFKnHgMpbl770ZzyPkhLNzzpi6SLnqdcG4LhioCordG7LiEspCgoK3ZMU0yEIrAYfkKKV7lkWVUu_IIfAKRMXUimy_R_xjexwc0tDSOYY7HLrJ9tQvLoy9Td4m2g10Fzzm2k1bmpY0oe8c7edxThTjMm3R2ymkfDv9sbk6-0zHiH3nu8HGhaZpbpb35KC1fcIPj-cx-fX16uflTbH5dn17-WVTOFDlVEihObSWNXlEga1swCmnQNaMubIRCrGubWtbXmpXoZLIhKjdupWW1RxBwjE53fuOMfyeMU3Gd8lh39sBw5yMAFhrrddaZPTTC_Q-zHHI02VK5d1VlS4zJfaUiyGliK0ZY-fzvwxn5iEHs8_B5BzMvxzMLos-PlrPtcfmWfK0-AzAHkj5abjD-L_3K7Z_AXb2lYM</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Alicja, Ekiel</creator><creator>Małgorzata, Romanik</creator><creator>Małgorzata, Aptekorz</creator><creator>Elżbieta, Semik-Grabarczyk</creator><creator>Paweł, Cieślik</creator><creator>Dominika, Smolec</creator><creator>Jarosław, Jóźwiak</creator><creator>Michał, Holecki</creator><creator>Gayane, Martirosian</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4603-9758</orcidid><orcidid>https://orcid.org/0000-0002-3289-1050</orcidid><orcidid>https://orcid.org/0000-0002-7343-4702</orcidid><orcidid>https://orcid.org/0000-0002-0311-0884</orcidid><orcidid>https://orcid.org/0000-0001-8601-1752</orcidid><orcidid>https://orcid.org/0000-0002-3723-3591</orcidid><orcidid>https://orcid.org/0000-0002-2998-6542</orcidid><orcidid>https://orcid.org/0000-0003-0377-9833</orcidid><orcidid>https://orcid.org/0000-0002-7871-528X</orcidid></search><sort><creationdate>20200401</creationdate><title>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</title><author>Alicja, Ekiel ; Małgorzata, Romanik ; Małgorzata, Aptekorz ; Elżbieta, Semik-Grabarczyk ; Paweł, Cieślik ; Dominika, Smolec ; Jarosław, Jóźwiak ; Michał, Holecki ; Gayane, Martirosian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Autoimmune diseases</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Chronic conditions</topic><topic>Etiology</topic><topic>Internal Medicine</topic><topic>Lupus</topic><topic>Medical Microbiology</topic><topic>Original Article</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alicja, Ekiel</creatorcontrib><creatorcontrib>Małgorzata, Romanik</creatorcontrib><creatorcontrib>Małgorzata, Aptekorz</creatorcontrib><creatorcontrib>Elżbieta, Semik-Grabarczyk</creatorcontrib><creatorcontrib>Paweł, Cieślik</creatorcontrib><creatorcontrib>Dominika, Smolec</creatorcontrib><creatorcontrib>Jarosław, Jóźwiak</creatorcontrib><creatorcontrib>Michał, Holecki</creatorcontrib><creatorcontrib>Gayane, Martirosian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alicja, Ekiel</au><au>Małgorzata, Romanik</au><au>Małgorzata, Aptekorz</au><au>Elżbieta, Semik-Grabarczyk</au><au>Paweł, Cieślik</au><au>Dominika, Smolec</au><au>Jarosław, Jóźwiak</au><au>Michał, Holecki</au><au>Gayane, Martirosian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>39</volume><issue>4</issue><spage>717</spage><epage>721</epage><pages>717-721</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups,
U. parvum
occurred significantly more frequently.
M. genitalium
was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs.
Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31832807</pmid><doi>10.1007/s10096-019-03783-w</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-4603-9758</orcidid><orcidid>https://orcid.org/0000-0002-3289-1050</orcidid><orcidid>https://orcid.org/0000-0002-7343-4702</orcidid><orcidid>https://orcid.org/0000-0002-0311-0884</orcidid><orcidid>https://orcid.org/0000-0001-8601-1752</orcidid><orcidid>https://orcid.org/0000-0002-3723-3591</orcidid><orcidid>https://orcid.org/0000-0002-2998-6542</orcidid><orcidid>https://orcid.org/0000-0003-0377-9833</orcidid><orcidid>https://orcid.org/0000-0002-7871-528X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0934-9723 |
ispartof | European journal of clinical microbiology & infectious diseases, 2020-04, Vol.39 (4), p.717-721 |
issn | 0934-9723 1435-4373 |
language | eng |
recordid | cdi_proquest_miscellaneous_2336999692 |
source | Springer Nature |
subjects | Autoimmune diseases Biomedical and Life Sciences Biomedicine Chronic conditions Etiology Internal Medicine Lupus Medical Microbiology Original Article Systemic lupus erythematosus |
title | Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A04%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20urogenital%20mycoplasmas%20in%20women%20with%20systemic%20lupus%20erythematosus%20(SLE):%20preliminary%20study&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Alicja,%20Ekiel&rft.date=2020-04-01&rft.volume=39&rft.issue=4&rft.spage=717&rft.epage=721&rft.pages=717-721&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-019-03783-w&rft_dat=%3Cproquest_cross%3E2336999692%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2379348895&rft_id=info:pmid/31832807&rfr_iscdi=true |